CDBT (China Dasheng Biotechnology Co) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2007. Start your Free Trial

What is China Dasheng Biotechnology Co Change In Payables And Accrued Expense?

China Dasheng Biotechnology Co's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2023 was $0.00 Mil. It means China Dasheng Biotechnology Co's Accounts Payable & Accrued Expense increased by $0.00 Mil from Jun. 2022 to Jun. 2023 .

China Dasheng Biotechnology Co's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2023 was $0.00 Mil. It means China Dasheng Biotechnology Co's Accounts Payable & Accrued Expense increased by $0.00 Mil from Jun. 2022 to Jun. 2023 .

China Dasheng Biotechnology Co Change In Payables And Accrued Expense Historical Data

The historical data trend for China Dasheng Biotechnology Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Dasheng Biotechnology Co Change In Payables And Accrued Expense Chart

China Dasheng Biotechnology Co Annual Data

Trend

Oct06

Oct07

Jun08

Jun22

Jun23

Change In Payables And Accrued Expense

-0.23

China Dasheng Biotechnology Co Semi-Annual Data
	Oct06	Oct07	Jun22	Jun23
Change In Payables And Accrued Expense	-	-	-	-

China Dasheng Biotechnology Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

China Dasheng Biotechnology Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of China Dasheng Biotechnology Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.